健脾利湿汤联合双歧杆菌三联活菌胶囊治疗溃疡性结肠炎的临床研究

http://www.100md.com 2019年9月1日《健康必读(上旬刊)》 20199

目的：,方法,结果,结论,AbstractObjective,Methods：,Results,Conclusion：,Keywords

     【摘要】目的：分析健脾利湿汤联合双歧杆菌三联活菌胶囊治疗溃疡性结肠炎的临床效果。方法：选择68例溃疡性结肠炎患者作为此次分析对象，选取2017.12～2019.5来我院就诊的患者，随机分组，分别给予美沙拉嗪、健脾利湿汤联合双歧杆菌三联活菌胶囊治疗，比较临床疗效、血清炎症因子水平。结果：观察组临床疗效高于对照组，血清炎症因子水平与对照组相比存在显著差异性，P<0.05。结论：健脾利湿汤联合双歧杆菌三联活菌胶囊治疗溃疡性结肠炎效果显著。

    【关键词】健脾利湿汤;双歧杆菌三联活菌胶囊;溃疡性结肠炎

    【中图分类号】R574.62 【文献标识码】A 【文章编号】1672-3783(2019)09-0064-01

    Clinical Study on Treatment of Ulcerative Colitis with Jianpi Lishi Decoction and Bifidobacterium Sanlian Live Capsule

    【Abstract】Objective：To analyze the clinical effect of Jianpi Lishi Decoction combined with Bifidobacterium Sanlian Live Capsule in the treatment of ulcerative colitis. Methods：68 patients with ulcerative colitis were selected as the target of this study. Patients who came to our hospital from 2017.12 to 2019.5 were randomly divided into three groups： Mesalazine ......

百拇医药网 http://www.100md.com/html/paper/1672-3783D/2019/09/103.htm

您现在查看是摘要页，全文长 4296 字符。